| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Jul―05 |
Remdesivir-Related Cardiac Adverse Effects in COVID-19 Patients: A
Case-Control Study |
Fatemah Abedipour, Hossein Hadavand Mirzaei, Hossein Ansari, Neda Ehsanzadeh, Amin Rashki, Mohammad Mahdi Vahedi, Asma Rashki |
| 2 |
[GO] |
2022―Aug―11 |
Pathway Analysis of Patients with Severe Acute Respiratory
Syndrome |
Anas Khaleel, Abdullah Bassam Zakariya, Mohammad Niazi, Nidal A. Qinna, Wael Abu Dayyih, Amneh H. Tarkhan |
| 3 |
[GO] |
2022―Jan―04 |
Phytoconstituents in the Management of Covid-19: Demystifying the
Fact |
Md. Abul Barkat, Pawan Kaushik, Harshita Abul Barkat, Mohammad Idreesh Khan, Hazrina Ab Hadi |
| 4 |
[GO] |
2021―Apr―23 |
A Concept for the Reduction of Mucosal SARS-CoV-2 Load using Hypochloric Acid Solutions |
Christian A. Mueller, Michael Winter, Bertold Renner |
| 5 |
[GO] |
2021―Jan―12 |
Macrophage Activation and Cytokine Release Syndrome in COVID-19:
Current Updates and Analysis of Repurposed and Investigational Anti-Cytokine
Drugs |
Ashif Iqubal, Farazul Hoda, Abul Kalam Najmi, Syed Ehtaishamul Haque |
| 6 |
[GO] |
2021―Jan―05 |
Development of a Physiologically-Based Pharmacokinetic (PBPK) Model of Nebulized Hydroxychloroquine for Pulmonary Delivery to COVID-19 Patients |
Nasir Idkaidek, Feras Hawari, Yasmeen Dodin, Nour Obeidat |
| 7 |
[GO] |
2021―Jan―05 |
Efficacy and Safety of Tocilizumab for Coronavirus Disease 2019 (Covid-19) Patients: A Systematic Review and Meta-analysis |
Timotius Ivan Hariyanto, Willie Hardyson, Andree Kurniawan |
| 8 |
[GO] |
2020―Dec―23 |
Therapeutic Approach Against 2019-nCoV by Inhibition of the ACE-2 receptor |
Gajendra Kumar, Dharmendra Kumar, Netra Pal Singh |
| 9 |
[GO] |
2020―Nov―13 |
Therapeutic Approach against 2019-nCoV by Inhibition of ACE-2 Receptor |
Gajendra Kumar, Dharmendra Kumar, Netra Pal Singh |
| 10 |
[GO] |
2020―Nov―11 |
Favipiravir and COVID-19: A Simplified Summary |
Morteza Ghasemnejad-Berenji, Sarvin Pashapour |
| 11 |
[GO] |
2020―Oct―30 |
Tutankhamun’s Antimalarial Drug for Covid-19 |
Andrei P. Sommer, Horst-Dieter Försterling, Katlin E. Sommer |
| 12 |
[GO] |
2020―Sep―02 |
The Potential Therapeutic Role of Proton Pump Inhibitors in COVID-19:
Hypotheses Based on Existing Evidences |
Avik Ray, Swati Sharma, Balakrishnan Sadasivam |
| 13 |
[GO] |
2020―Aug―03 |
Coronavirus Disease-2019 (COVID-19): An Updated
Review |
Mithun Rudrapal, Shubham J. Khairnar, Laxmikant B. Borse, Anil G. Jadhav |
| 14 |
[GO] |
2020―Jun―19 |
The Battle against COVID 19 Pandemic: What we Need to Know Before we
“Test Fire” Ivermectin |
Kushal Banerjee, Manab Nandy, Chanchal Kumar Dalai, Shah Newaz Ahmed |
| 15 |
[GO] |
2020―May―22 |
Interferons in the Therapy of Severe Coronavirus Infections: A Critical Analysis and Recollection of a Forgotten Therapeutic Regimen with Interferon Beta |
Josef Brzoska, Harald von Eick, Manfred Hündgen |
| 16 |
[GO] |
2020―May―19 |
Potential Unconventional Medicines for the Treatment of SARS-CoV-2 |
Maurizio Coppola, Raffaella Mondola |
